VBI Vaccines
VBIV
#10520
Rank
HK$14.64 M
Marketcap
HK$0.51
Share price
0.00%
Change (1 day)
-89.23%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): -HK$79.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -HK$79.29. In 2022 the company made an earnings per share (EPS) of -HK$103.21 a decrease over its 2021 EPS that were of -HK$63.33.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$79.49
2022-HK$103.2162.96%
2021-HK$63.3328.57%
2020-HK$49.26-54.35%
2019-HK$107.90-52.58%
2018-HK$227.5410.23%
2017-HK$206.4314.29%
2016-HK$180.62-62.8%
2015-HK$485.5790.68%
2014-HK$254.65-7.95%
2013-HK$276.66-57.97%
2012-HK$658.31-78%
2011-HK$2,9933151.47%
2010-HK$92.0423.87%
2009-HK$74.31-18.48%
2008-HK$91.1612.08%
2007-HK$81.34-49.47%
2006-HK$160.97
2005N/A-100%
2004-HK$71.5611.94%
2003-HK$63.93-81.89%
2002-HK$352.99196.44%
2001-HK$119.0784.33%
2000-HK$64.60-65.37%
1999-HK$186.54-29.45%
1998-HK$264.4029.61%
1997-HK$203.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.43-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-HK$28.70-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$33.86-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA